“Valneva SE (“Valneva” or “the Company”), a specialty vaccine company, and Serum Institute of India (SII), the world’s ...

Check the time stamp on this data. Updated AI-Generated Signals for Sprott Inc. (SII) available here: SII.

Denmark: Bavarian Nordic A/S has announced a license and manufacturing agreement for its MVA-BN mpox vaccine with Serum ...

SII), is a leading global exchange-traded funds (ETFs) asset manager with a specialty in precious metals and energy transition investments.

India reported the first case of mpox disease caused by the “clade 1b” strain that prompted WHO to declare the infection a ...

As Bavarian Nordic works to increase global access to its mpox vaccine, the company has inked a manufacturing licensing pact ...

Sprott continues to demonstrate strong financial health with an impressive annual earnings growth of 20.4% over the past five years, significantly outpacing the industry average. Recently, the ...

Researchers conducted a retrospective study to assess serum inflammatory biomarkers in patients with different subtypes of ...

Bavarian Nordic will transfer the technology of the current manufacturing process to SII to enable supply for the Indian ...

Saint-Herblain (France), Pune, (India), December 19, 2024 – Valneva SE (“Valneva” or “the Company”), a specialty vaccine company, and Serum Institute of India (SII), the world’s largest manufacturer ...

The funding round was led by Serum Institute of India (SII) with participation from the European Innovation Council (EIC) Fund and other investors. Proceeds will support key activities, including ...

Valneva will supply its chikungunya vaccine drug substance to SII, which will complete manufacturing and be responsible for ...